Clinical Trial Update: Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures

View source ↗

Summary

A Zhejiang University-backed study aims to enable early diagnosis of resectable pancreatic cancer by deciphering multi-modal immunological signatures; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Zhejiang University | Conditions: Pancreatic Cancer Resectable | Status: NOT_YET_RECRUITING